Copyright
©2010 Baishideng. All rights reserved.
World J Gastroenterol. Jul 28, 2010; 16(28): 3601-3602
Published online Jul 28, 2010. doi: 10.3748/wjg.v16.i28.3601
Published online Jul 28, 2010. doi: 10.3748/wjg.v16.i28.3601
Role of endoscopic ultrasound/SpyScope in diagnosis and treatment of choledocholithiasis in pregnancy
Mohit Girotra, Niraj Jani, Division of Gastroenterology, Department of Medicine, Johns Hopkins University/Sinai Hospital Program in Internal Medicine, Baltimore, MD 21215, United States
Author contributions: Girotra M and Jani N contributed equally to the designing, writing and editing of the manuscript.
Correspondence to: Mohit Girotra, MD, Division of Gastroenterology, Department of Medicine, Johns Hopkins University/Sinai Hospital Program in Internal Medicine, 2401 W Belvedere Ave, Baltimore, MD 21215, United States. girotra.mohit@gmail.com
Telephone: +1-410-6019000 Fax: +1-410-6014919
Received: April 17, 2010
Revised: May 27, 2010
Accepted: June 4, 2010
Published online: July 28, 2010
Revised: May 27, 2010
Accepted: June 4, 2010
Published online: July 28, 2010
Abstract
Cholelithiasis and choledocholithiasis occur frequently in pregnancy and their management can be complicated. Traditional endoscopic retrograde cholangiopancreatography (ERCP) is the first line treatment for choledocholithiasis, but in addition to its baseline risks, fluoroscopy poses an additional radiation risk to the fetus. Endoscopic ultrasound (EUS) is an accurate modality for detecting common bile duct stones, but its role has not been defined in pregnancy. We describe an alternative management strategy to conventional ERCP in a pregnant patient with choledocholithiasis and cholangitis detected using EUS and choledochoscopy.
Keywords: SpyScope, Endoscopic ultrasound, Choledocholithiasis, Management, Pregnancy